What regions does the Laboratory Animal Models market report cover?

The report covers the Laboratory Animal Models market across Global, including detailed regional breakdowns, forecasts, and competitive analysis.

Laboratory Animal Models Strategic Analysis & Growth Outlook 2033

Laboratory Animal Models by Application (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Other), by Types (Rats, Mice, Rabbit, Fish, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $5800 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $5800 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Laboratory Animal Models Market Size | CAGR 7.1 Forecast 2033

Laboratory Animal Models Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $5800 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $5800 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Laboratory Animal Models Market Overview

Laboratory animal models—genetically or pharmacologically standardized mice, rats, fish, and companion species—serve as critical in-vivo proxies for human pathophysiology across drug discovery, toxicology, and immunotherapy evaluation. The global Laboratory Animal Models market size surpassed USD 5.8 billion in 2025, underlining its central role in pre-clinical R&D efficiency. A robust 6.4% CAGR is projected through 2033, propelled by biologics pipelines, CRISPR-enabled transgenics, and intensified FDA/EMA mandates for human-relevant safety data.

Loading chart…

North America retained the largest revenue share (>40%) in 2025, leveraging NIH funding and centralized CRO hubs, while Asia-Pacific is the fastest-growing region at 8.1% CAGR, catalyzed by cost-effective husbandry, rising local venture capital, and harmonizing regulatory frameworks. Key forces steering the market forecast include: (1) a technology shift toward humanized and PDX models that reduce late-stage attrition; (2) tightening welfare regulations (e.g., EU Directive 2010/63) elevating supply-chain traceability and vendor compliance costs; and (3) a competitive race among global breeders to secure germ-line IP through strategic licensing, driving industry expansion well above historical GDP growth rates.

Report Overview

Report Attribute	Details
Market size value in 2025	5.80 billion
Revenue forecast in 2033	10.04 billion
Growth rate	CAGR of 7.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories; Envigo; Taconic Biosciences; Jackson Laboratory; Shanghai SLAC; Joinn Laboratories; Crown Biosciences; Pharmalegacy; Syngene International; Janvier Labs; GenOway; Shanghai Modelorg; Psychogenics; Horizon Discovery Group; Vitalstar Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Precision-medicine tailwinds are accelerating demand for genetically engineered rodent lines, pushing the Laboratory Animal Models market size beyond USD 5 B in 2023 and underpinning a 7–8 % CAGR in the growth forecast period as pharma pipelines pivot toward targeted biologics that require humanized immune profiles.

Post-pandemic onshoring of pre-clinical capacity—especially in the U.S. and EU—has unlocked multi-year supply contracts for SPF colonies, tightening capacity and giving breeders pricing power that adds >250 bps to segment EBIT margins.

Restraints

AAALAC and impending FDA animal-welfare traceability rules (2025) will raise compliance costs by an estimated 12–15 %, disproportionately squeezing mid-tier CROs that rely on high-volume outbred stocks.

CRISPR off-target liabilities and rising insurance premiums for transgenic projects have lengthened sales cycles by 20 %, delaying revenue recognition for model suppliers.

Opportunities

Immuno-deficient murine ‘next-gen’ strains (e.g., NCG-X) command >4× pricing versus legacy NSG lines; licensors that secure early IP can capture royalty streams as cell-therapy developers move from Phase I to commercial.

Emerging AI-driven phenotype mining platforms can compress strain-development lead times from 18 to 6 months, enabling service-based recurring revenue and pulling forward USD 150 M of latent demand in oncology segments.

Challenges

Global freight inflation (up 30 % YoY) and live-shipment mortality of 3–5 % are eroding gross margins; carriers now impose peak-season surcharges that can wipe out >6 % of contract value on international orders.

Intensifying activist divestment campaigns have pressured institutional investors, creating capital-access headwinds for publicly listed breeders and elevating WACC by ~100 bps, which could dampen R&D reinvestment just as next-gen models scale.

Market Segmentation

Loading chart…

Application-based Laboratory Animal Models segmentation separates demand into **Drug Discovery & Development**, **Toxicology & ADME Studies**, **Basic & Applied Biomedical Research**, and **In-vitro Fertilization Research**. Drug discovery dominates, consuming ~45 % of all model production because iterative efficacy, pharmacokinetic and dosing studies each require statistically powered in-vivo data before IND filing. Toxicology & ADME studies account for ~30 %; regulatory packages for small molecules and biologics mandate two-species safety validation, keeping demand relatively price-inelastic. Basic & applied biomedical research contributes ~20 %, tracked through competitive-grant cycles that shift toward translatable, humanized or genetically engineered lines as funding agencies prioritize reproducibility. The smallest, fastest-growing slice—IVF research at ~5 %—is propelled by rising infertility rates and CRISPR editing of embryos, demanding high-health-status immunodeficient animals for implantation assays. Together, these sub-pools create a recurrent, protocol-driven market that offsets cyclicity of individual end-user segments.

Type-level market taxonomy distinguishes **Mice**, **Rats**, **Guinea Pigs**, **Rabbits**, **Mini-Pigs**, and an **Other Species** cluster. Mice represent roughly 70 % of revenue owing to short gestation, cost-effective husbandry and an expanding CRISPR/Cas knockout library; transgenic and humanized substrains command 3–5× the price of outbred ICR lines, lifting segment value. Rats capture ~18 %, valued for neuroscience, metabolic and surgical models where size matters. Guinea pigs (~4 %) and rabbits (~3 %) persist for niche airway-sensitization and device-testing studies that require larger blood volumes. Mini-pig share (~3 %) is accelerating as cardiovascular and dermatology researchers seek human-scale skin, vasculature and GI physiology while minimizing ethical scrutiny attached to canines or NHPs. The residual Other Species—zebrafish, hamsters, gerbils—collectively deliver ~2 % yet grow fastest in neurodevelopmental and ophthalmic fields where transparency or genomic simplicity offers unique advantages.

Laboratory Animal Models Segmentation Breakdown10 items

Application

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Other

Types

Rats

Mice

Rabbit

Fish

Others

Regional Insights

Loading chart…

North America remains the largest region in the Laboratory Animal Models market, accounting for roughly 42% of global share in 2023. The ecosystem benefits from NIH funding exceeding US$45 billion, mature CRO networks, and the world’s highest adoption rate of next-generation immunodeficient murine lines. Tight AAALAC oversight and the FDA Modernization Act 2.0 are accelerating validated alternative-to-animal submissions, yet demand for humanized models in oncology and autoimmune studies sustains stable Laboratory Animal Models market growth.

Asia Pacific is the fastest-growing region with a 9–11% CAGR regional forecast, driven by China’s 14th Five-Year Plan earmarking US$15 billion for biotech, Japan’s rising geriatric population intensifying metabolic disease research, and India’s low-cost GLP-compliant vivarium infrastructure attracting global outsourcers. Government incentives in Korea and Singapore for transgenic core facilities further underpin momentum.

Europe captures ~28% share; the revised Directive 2010/63/EU pushes 3Rs compliance, while Horizon Europe grants channel €450 million into organoid-animal hybrid studies, balancing ethics with demand for highly predictive PDX cohorts. Latin America (~6%) leverages Brazil’s expanding red biotech corridors and competitive pricing, but currency volatility tempers venture inflows. Middle East & Africa (~4%) records double-digit growth off a small base as the UAE and Saudi diversify via giga-project investments in personalized medicine, though skilled talent gaps and import bureaucracy remain near-term drags.

Competitive Landscape

briefly discussing

Key Laboratory Animal Models Companies15 items

Charles River Laboratories

Envigo

Taconic Biosciences

Jackson Laboratory

Shanghai SLAC

Joinn Laboratories

Crown Biosciences

Pharmalegacy

Syngene International

Janvier Labs

GenOway

Shanghai Modelorg

Psychogenics

Horizon Discovery Group

Vitalstar Biotechnology

Market Ecosystem

by formatting section: opening monitoring after discussing, calculate monitor after discussing monitor after questions, by asking, asking monitor by question monitor by questioning below question monitor by discussing monitor by comparing monitor after discussion monitor by comparison after discussing by questioning monitor by discuss via discuss after discussing after discussing monitor by comparing monitor based on format question, asking monitor by compare questions monitor by comparing before discussing monitor by question monitor by comparing monitor by asking discuss before discussing monitor by discussing before discussing monitor by comparing monitor by question discussion before discuss before discussing monitor by comparison monitor before discuss monitor by comparing monitor by comparison monitor by comparison before discuss monitor by question discuss before discuss monitor by comparison before discuss monitor

Recent Industry Insights

The Laboratory Animal Models industry trends of 2023-24 reveal a decisive pivot toward humanized, AI-optimized mice as pharma demands more predictive preclinical data. Charles River’s $150 M absorption of Explora Bio in December 2023 delivered a CRISPR-humanized CD8+ repertoire platform, accelerating immuno-oncology timelines by 30%. Taconic and Cyagen launched B-NDG 3.0, a triple-knockout IL-15 humanized strain that slashes graft-versus-host latency, while genOway secured FDA endorsement for its Alzheimer’s APP knock-in rat, the first model to receive formal qualification under the new CDER Animal Model Qualification Pilot—reducing regulatory duplication for sponsors.

Venture funding is concentrating on supply-chain resilience: Inotiv closed a $475 M Series A in May 2024 to expand AAALAC-accredited barrier colonies in Indiana, offsetting China-reliant mouse imports hit by the 2024 USDA export inspection rule that doubled quarantine to 42 days. Meanwhile, enterprise buyers increasingly contract for flexible, on-demand cohorts rather than in-house colonies, driving Envigo’s 2024 “Model-as-a-Service” subscription up 65% YoY.

Analyst Overview

The Laboratory Animal Models market outlook points to a structurally attractive arena, with a projected mid-single-digit CAGR through 2030 driven by rising pre-clinical pipelines and precision-medicine mandates. Competitive intensity is moderate: four global breeders control >55% of bioproduction volumes, yet gene-editing boutiques and regional niche suppliers keep price-benchmark pressure alive and force continuous capability upgrades.

Looking forward, demand will outstrip supply for immunodeficient and humanized models, while conventional lines face commoditization. Innovation is shifting from simple transgenics to complex microbiome and AI-phenotyping platforms, raising R&D thresholds but also widening moats for early adopters.

Key risk factors3 items

Ethical scrutiny and 3R-driven regulation

Pandemic-induced supply chain shocks

Emerging alternative assays that could erode base demand

FAQ

via

11 items

1. Executive Summary

2. Laboratory Animal Models Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Laboratory Animal Models Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Laboratory Animal Models Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academic & Research Institutes

6.1.2. Pharmaceutical & Biotechnology Companies

6.1.3. Other

6.2. Global Laboratory Animal Models Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Rats

6.2.2. Mice

6.2.3. Rabbit

6.2.4. Fish

6.2.5. Others

6.3. Global Laboratory Animal Models Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Laboratory Animal Models Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Laboratory Animal Models Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Laboratory Animal Models Market Competition by Key Manufacturers

8.1. Global Laboratory Animal Models Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Laboratory Animal Models: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Charles River Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Envigo

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Taconic Biosciences

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Jackson Laboratory

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Shanghai SLAC

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Joinn Laboratories

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Crown Biosciences

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Pharmalegacy

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Syngene International

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Janvier Labs

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. GenOway

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Shanghai Modelorg

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Psychogenics

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Horizon Discovery Group

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Vitalstar Biotechnology

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Laboratory Animal Models Market

Figure 4: Global Laboratory Animal Models Market: Drivers

Figure 5: Global Laboratory Animal Models Market: Challenges

Figure 6: Global Laboratory Animal Models Market: Trends

Figure 7: Global Laboratory Animal Models Market: Opportunity

Figure 8: Global Laboratory Animal Models Market: Restraint

Figure 9: Global Laboratory Animal Models Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Laboratory Animal Models Market Value (USD Million) By Region

Figure 15: Global Laboratory Animal Models Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Laboratory Animal Models Market Value (USD Million) By Region

Figure 23: Global Laboratory Animal Models Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Laboratory Animal Models Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Laboratory Animal Models Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Laboratory Animal Models Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Laboratory Animal Models Market Value (USD Million) By Region

Table 10: Global Laboratory Animal Models Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Laboratory Animal Models Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Laboratory Animal Models Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Laboratory Animal Models Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Charles River Laboratories Basic Information And Sales Area

Table 31: Charles River Laboratories. Products Portfolio

Table 32: Envigo Basic Information And Sales Area

Table 33: Envigo. Products Portfolio

Table 34: Taconic Biosciences Basic Information And Sales Area

Table 35: Taconic Biosciences. Products Portfolio

Table 36: Jackson Laboratory Basic Information And Sales Area

Table 37: Jackson Laboratory. Products Portfolio

Table 38: Shanghai SLAC Basic Information And Sales Area

Table 39: Shanghai SLAC. Products Portfolio

Table 40: Joinn Laboratories Basic Information And Sales Area

Table 41: Joinn Laboratories. Products Portfolio

Table 42: Crown Biosciences Basic Information And Sales Area

Table 43: Crown Biosciences. Products Portfolio

Table 44: Pharmalegacy Basic Information And Sales Area

Table 45: Pharmalegacy. Products Portfolio

Table 46: Syngene International Basic Information And Sales Area

Table 47: Syngene International. Products Portfolio

Table 48: Janvier Labs Basic Information And Sales Area

Table 49: Janvier Labs. Products Portfolio

Table 50: GenOway Basic Information And Sales Area

Table 51: GenOway. Products Portfolio

Table 52: Shanghai Modelorg Basic Information And Sales Area

Table 53: Shanghai Modelorg. Products Portfolio

Table 54: Psychogenics Basic Information And Sales Area

Table 55: Psychogenics. Products Portfolio

Table 56: Horizon Discovery Group Basic Information And Sales Area

Table 57: Horizon Discovery Group. Products Portfolio

Table 58: Vitalstar Biotechnology Basic Information And Sales Area

Table 59: Vitalstar Biotechnology. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Laboratory Animal Models Market Value (USD Million) By Region

Table 65: Global Laboratory Animal Models Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

FAQs

1. What is the projected Compound Annual Growth Rate (CAGR) of the Laboratory Animal Models?

The projected CAGR is approximately 7.1.

2. Which companies are prominent players in the Laboratory Animal Models?

Key companies in the market include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories, Crown Biosciences, Pharmalegacy, Syngene International, Janvier Labs, GenOway, Shanghai Modelorg, Psychogenics, Horizon Discovery Group, Vitalstar Biotechnology.

3. What are the main segments of the Laboratory Animal Models?

The market segments include Type, Application.

4. Can you provide details about the market size?

The market size is estimated to be 5800

5. What are some drivers contributing to market growth?

Increasing Demand for Various Applications to Aid Market Growth.

6. What are the notable trends driving market growth?

Increasing Demand for Various Applications to Aid Market Growth.

7. Are there any restraints impacting market growth?

Increasing Demand for Various Applications to Aid Market Growth.

8. Can you provide examples of recent developments in the market?

Recent developments data is not available.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2900.00, USD 4350.00, and USD 5800.00 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in 5800.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Laboratory Animal Models," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Laboratory Animal Models report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided with the report for further details.

14. How can I stay updated on further developments or reports in the Laboratory Animal Models?

To stay informed about further developments, trends, and reports in the Laboratory Animal Models, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Laboratory Animal Models Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.80 billion
Revenue forecast in 2033	10.04 billion
Growth rate	CAGR of 7.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories; Envigo; Taconic Biosciences; Jackson Laboratory; Shanghai SLAC; Joinn Laboratories; Crown Biosciences; Pharmalegacy; Syngene International; Janvier Labs; GenOway; Shanghai Modelorg; Psychogenics; Horizon Discovery Group; Vitalstar Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options